CCL5 and neoplasm: Our results indicate that epigenetic priming mediates the rapid secretion of key tumor-derived cytokines known to augment T and NK cell activation and cytotoxicity, including IL-6, IP-10 (CXCL10), KC (CXCL1), and RANTES (CCL5).